IW-6463

Cyclerion fails sickle cell test, prompting pivot to CNS disease
Fierce Biotech
Wed, 10/14/20 - 10:46 am
Cyclerion
olinciguat
sickle cell disease
CNS
IW-6463
Ironwood Pharmaceuticals initiates phase 1 trial of IW-6463
Pharmaceutical Business Review
Thu, 01/24/19 - 10:55 am
Ironwood Pharmaceuticals
IW-6463
CNS disorders
clinical trials